4.5 Review

Olopatadine 0.2% ophthalmic solution: the first ophthalmic antiallergy agent with once-daily dosing

Journal

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY
Volume 4, Issue 4, Pages 453-461

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1517/17425255.4.4.453

Keywords

antiallergy; antihistamine; olopatadine; ophthalmic

Ask authors/readers for more resources

Background: Olopatadine 0.2% is the first topical ophthalmic antihistamine/mast cell stabilizer indicated for once-daily dosing. Objective: This review provides a comprehensive description of the pharmacology of the olopatadine molecule, as well as of the clinical efficacy, tolerability, and safety of olopatadine 0.2% ophthalmic solution. Methods: References cited in this review were obtained from the PubMed biomedical literature database. Also included were several posters presented at nationally renowned ophthalmology-related conferences. Results/conclusion: Olopatadine 0.2% was found to be a safe and effective medication for the reduction of itching with a duration of action of up to 24 h. The added convenience of a once-a-day dosing regimen is a major advancement in this drug class.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available